Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
DuraSeal Sealant gets CE Mark for thoracic applications
October 23rd, 2005
Confluent Surgical, Inc., announced that a CE Mark has been granted for the DuraSeal Sealant System for use as a surgical sealant during elective pulmonary resection as an adjunct to standard closure techniques of visceral pleural air leaks. By providing an airtight seal in lung surgery, DuraSeal Sealant will, according to the company, offer surgeons operating on the lung a valuable tool to prevent postoperative complications associated with alveolar air leaks. The DuraSeal technology is a patented synthetic, absorbable hydrogel delivered by a dual-syringe applicator. The device can be stored at room temperature and prepared in less than 2 minutes....
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
